Cell-derived Giant Membrane Vesicles Enclosing the Anthracycline Anti-Cancer Drug Doxorubicin and their Cytotoxicity

Authors

  • Saya Okada Department of Biological Science, Graduate School of Science and Technology, Kumamoto University, Kumamoto, Japan
  • Hisato Saitoh Department of Biological Science, Graduate School of Science and Technology, Kumamoto University, Kumamoto, Japan; Faculty of Advanced Science and Technology (FAST), Kumamoto University, Kumamoto, Japan

DOI:

https://doi.org/10.15379/ijmst.v9i1.1033

Abstract

Abstract: Although giant membrane vesicles prepared from paraformaldehyde-treated mammalian cells have been used to elucidate lipid and protein dynamics on the cell surface, there are few studies that have used them as a tool to deliver drugs to cells. Here we found that anti-cancer drug doxorubicin (Dox) was efficiently incorporated into and stably retained in giant membrane vesicles prepared from HeLa human cervical cancer cells. Intriguingly, coincubation of Dox-enclosed giant membrane vesicles with human pancreatic cancer-derived PK-59 and gastric cancer-derived KE-39 cells led to cell death. Microscopic observation of vesicle-docked cells revealed that docking of at least one to a few Dox-enclosed giant vesicles on the cellular cortex was sufficient to induce cell death, suggesting applicability of cell-derived giant membrane vesicles as an efficient drug delivery vector in cultured cell systems.

Keywords: Anti-cancer treatment, Extracellular vesicle, Doxorubicin, Drug delivery.

Downloads

Download data is not yet available.

Downloads

Published

2022-06-25

How to Cite

[1]
S. Okada and H. Saitoh, “Cell-derived Giant Membrane Vesicles Enclosing the Anthracycline Anti-Cancer Drug Doxorubicin and their Cytotoxicity”, ijmst, vol. 9, no. 1, pp. 13-19, Jun. 2022.

Issue

Section

Articles